Journey Medical Corp
DERM
Get informed when a big investor buys or sells
+ FollowMarket Cap$176.96M
Close$
$-5.57
183.7% downside
Current Fair Value
183.7% downsideOvervalued by 183.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $176.96 Million |
|---|---|
| Enterprise Value | $175.28 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.47 |
| Beta | 1.07 |
| Outstanding Shares | 27,305,028 |
Return
| Return on Equity | -31.10% |
|---|---|
| Return on Assets | -10.47% |
| Return on Invested Capital | -13.41% |
Valuation & Multiples
| P/E Ratio | -17.11 |
|---|---|
| PEG | 37.8 |
| Price to Sales | 3.33 |
| Price to Book Ratio | 6.65 |
| Enterprise Value to Revenue | 2.71 |
| Enterprise Value to EBIT | -24.34 |
| Enterprise Value to Net Income | -19 |
| Total Debt to Enterprise | 0.15 |
| Debt to Equity | 0.83 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 12, 2026
EPS Estimate
$-0.02
Average shareholder expectationRevenue Estimate
$18.36 M
Average shareholder expectationNext Earnings Call
Expected Date
November 11, 2026
EPS Estimate
$0.01
Average shareholder expectationRevenue Estimate
$21.89 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 12.47%▼ 30.94% |
|---|---|
| Total Invested | $24.11M▼ 56.73% |
| Investors Holding | 19▼ 53.00% |
ESG Score
No data